1. Home
  2. News
  3. Telix Pharmaceuticals Limited
  4. Q3 2022 Business Update to accompany quarterly results
More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Q3 2022 Business Update to accompany quarterly results

Oct 19, 2022 at 10:21 PM EDT · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Oct 19, 2022 at 10:21 PM EDT · 17 pages · English

On 6ix: 6ix.com/news/q3-2022-business-update-to-accompany-quarterly-results

Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20↗

Telix Pharmaceuticals Limited on 6ix

In the deck

  • Telix Pharmaceuticals — Q3 2022 Earnings Presentation17 slidesOct 20, 2022

Earlier from Telix Pharmaceuticals

  • Appendix 4C and Activities Report - September 2022 QuarterOct 19, 2022
  • TLX250-CDx Indication Expansion - Preliminary DataOct 17, 2022
  • Expansion of partnership with GE Healthcare in PET imagingOct 16, 2022
  • Health Canada Approves Illuccix for Prostate Cancer ImagingOct 13, 2022
  • Chinese NMPA Approves TLX250 Phase III registration studySep 27, 2022

Later from Telix Pharmaceuticals

  • ZIRCON Ph III Imaging Study - Positive Top-Line ResultsNov 6, 2022
  • ZIRCON Ph III Imaging Study - Top-Line data presentationNov 6, 2022
  • Telix Acquires Optimal TracersNov 13, 2022
  • ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GUDec 21, 2022
  • Webcast link correction - JP Morgan Conference PresentationJan 10, 2023
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer